Literature DB >> 28008607

MicroRNA-320a and microRNA-4496 attenuate Helicobacter pylori cytotoxin-associated gene A (CagA)-induced cancer-initiating potential and chemoresistance by targeting β-catenin and ATP-binding cassette, subfamily G, member 2.

Dong Woo Kang1,2, Eun Sun Yang1, Yu Na Noh1, Won Chan Hwang1, Se-Young Jo2, Young-Ah Suh2, Won Sang Park3, Kang-Yell Choi4,5, Do Sik Min1,5.   

Abstract

Infection with Helicobacter pylori is closely linked to an increased risk of gastric cancer. Although cytotoxin-associated gene A (CagA), a major virulence factor of H. pylori, is known to be a causal factor for gastric carcinogenesis, the molecular link between CagA and gastric cancer-initiating cell (CIC)-like properties remains elusive. Here, we demonstrate that CagA is required for increased expression of β-catenin and its target CIC markers via downregulation of microRNA (miR)-320a and miR-4496. CagA promoted gastric CIC properties and was responsible for chemoresistance. miR-320a and miR-4496 attenuated the in vitro self-renewal and tumour-initiating capacity of CagA-expressing CICs by targeting β-catenin. Moreover, miR-320a and miR-4496 decreased CagA-induced chemoresistance by targeting ATP-binding cassette, subfamily G, member 2 (ABCG2) at the transcriptional and post-transcriptional levels, respectively. Combination therapy with 5-fluorouracil and miR-320a/miR-4496 suppressed gastric tumourigenesis and metastatic potential in an orthotopic mouse model, probably via suppression of CagA-induced CIC properties and chemoresistance. Our results provide novel evidence that CIC properties, chemoresistance and tumourigenesis associated with H. pylori are linked to CagA-induced upregulation of β-catenin and ABCG2. These data provide novel insights into the molecular mechanisms of CagA-induced carcinogenisis and the therapeutic potential of of miR-320a and miR-4496.
Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  ABCG2; Helicobacter pylori CagA; chemoresistance; gastric cancer-initiating cells; miR-320a; miR-4496; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 28008607     DOI: 10.1002/path.4866

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

Review 1.  Clinical crosstalk between microRNAs and gastric cancer (Review).

Authors:  Jing Ouyang; Zhizhong Xie; Xiaoyong Lei; Guotao Tang; Runliang Gan; Xiaoyan Yang
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

2.  miRNAs reshape immunity and inflammatory responses in bacterial infection.

Authors:  Xikun Zhou; Xuefeng Li; Min Wu
Journal:  Signal Transduct Target Ther       Date:  2018-05-25

3.  Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity.

Authors:  Dong Woo Kang; Won Chan Hwang; Yu Na Noh; Kang Seo Park; Do Sik Min
Journal:  J Pathol       Date:  2020-09-10       Impact factor: 7.996

4.  The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.

Authors:  Tian Xiang; Chunhui Yuan; Xia Guo; Honghao Wang; Qinzhen Cai; Yun Xiang; Wei Luo; Gao Liu
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

5.  CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.

Authors:  Yao-Feng Li; Wen-Chiuan Tsai; Chung-Hsing Chou; Li-Chun Huang; Shih-Ming Huang; Dueng-Yuan Hueng; Chia-Kuang Tsai
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

6.  A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients.

Authors:  Qi Chen; Fanyi Meng; Lei Wang; Yong Mao; Huan Zhou; Dong Hua; Hongjian Zhang; Weipeng Wang
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

Review 7.  The impacts of H. pylori virulence factors on the development of gastroduodenal diseases.

Authors:  Wei-Lun Chang; Yi-Chun Yeh; Bor-Shyang Sheu
Journal:  J Biomed Sci       Date:  2018-09-11       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.